News & Updates
Filter by Specialty:
Early 3-day remdesivir course may prevent COVID-19 hospitalization, death
An early, 3-day regimen of remdesivir may prevent hospitalization and death in patients with COVID-19 who are at risk for disease progression, according to results of the PINETREE study.
Early 3-day remdesivir course may prevent COVID-19 hospitalization, death
26 Jan 2022Which AECOPD patients are likely to test positive for flu?
In patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD), higher body temperature and heart rate, along with low white cell counts, are strong predictors of testing positive for influenza, according to a recent Singapore study.
Which AECOPD patients are likely to test positive for flu?
25 Jan 2022Metabolic syndrome linked to greater COVID-19 severity
Individuals with metabolic syndrome who are hospitalized for COVID-19 may have a greater risk for more severe COVID-19 disease, including an elevated risk of in-hospital mortality, acute respiratory distress syndrome (ARDS), and intensive care unit (ICU) admission, a recent prospective study showed.
Metabolic syndrome linked to greater COVID-19 severity
21 Jan 2022Aspirin does not cut death risk in hospitalized COVID-19 patients
Adding aspirin to usual care did not lead to a reduced mortality rate in patients hospitalized with COVID-19, according to a study by the RECOVERY* Collaborative Group.